Heiko Schiwek

Heiko Schiwek is a Partner in the Linklaters’ Mergers & Acquisitions group in New York and one of the Global Leaders of the Chemicals Sector.

Heiko has extensive and diverse M&A experience ranging from public company acquisitions to complex carve-out sales, strategic investments and joint venture transactions and represents many of the largest US and non-US corporate clients.

Work highlights:

Heiko’s recent deal highlights include advising*:

• Dow Chemical in numerous transactions, including in its US$130bn transaction with DuPont involving the combination of the two companies, the subsequent separation into three public companies and the resulting US$50bn spin-off of Dow Inc.; the US$5bn Reverse Morris Trust transaction with Olin involving Dow’s chlor-alkali and derivatives business; the negotiations of the US$17.4bn K-Dow joint venture with PIC of Kuwait; the US$4.8bn strategic ownership restructuring of Dow Corning; the US$1.5bn sale of its MEGlobal joint venture interest to EQUATE; the US$1.63bn sale of Styron to Bain Capital; the sale of Dow’s global polypropylene business to Braskem; the divestiture of its global polypropylene licensing & catalysts business to W. R. Grace & Co; the sale of its interest in Nippon Unicar Company to the Tonen Group; the sale of its acid copolymers and ionomers business to SK Global Chemical Co.; the sale of Dow’s extruded polystyrene foam (XPS) business; the sale of Dow’s German S/A Latex business and the separation of Dow’s joint venture with Toray Industries, Inc.
• Celanese in numerous transactions, including in its US$11bn acquisition of the mobility and materials business of DuPont; the restructuring of its 50/50 Korea Engineering Plastics Co. joint venture with Mitsubishi Gas Chemical Company; the US$1.575bn divestiture of its interest in its Polyplastics joint venture to Daicel Corporation; and its food ingredients joint venture with Mitsui.
• LyondellBasell in its US$2.25bn acquisition of A. Schulman and other transactions.
• LANXESS in numerous transactions, including in its acquisition of the clean and disinfect business of Chemours; its acquisition of the US phosphorus additives business of Solvay; its acquisition of Emerald Kalama Chemical from American Securities; and its acquisition of the microbial control business of IFF.
• Dover Corporation in numerous transactions, including in its acquisition of FW Murphy Production Controls; and its acquisition of Espy Corporation.
• KMG Chemicals in its US$1.6bn sale to Cabot Microelectronics Corporation.
• SPX Technologies in its divestiture of subsidiaries holding asbestos liabilities and related assets to a joint venture of Global Risk Capital and Premia Holdings and its related Section 251(g) reorganization.

*The above matters were handled by Heiko prior to joining Linklaters.

Heiko joined Linklaters in 2024. Prior to joining Linklaters, he was a Partner in the M&A team at Shearman & Sterling LLP.

Heiko holds an LL.M. from Pennsylvania State University, The Dickinson School of Law. He also obtained a Dr. iur from the University of Dresden.